These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8793571)

  • 1. Evaluation of patients with minimally obstructive coronary artery disease and angina.
    Hasdai D; Cannan CR; Mathew V; Holmes DR; Lerman A
    Int J Cardiol; 1996 Mar; 53(3):203-8. PubMed ID: 8793571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain.
    Hasdai D; Holmes DR; Higano ST; Burnett JC; Lerman A
    Mayo Clin Proc; 1998 Dec; 73(12):1133-40. PubMed ID: 9868410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced vasomotor responses of complex coronary stenoses to acetylcholine in stable angina pectoris.
    Tousoulis D; Crake T; Kaski JC; Rosen SD; Haider AW; Davies GJ
    Am J Cardiol; 1995 Apr; 75(10):725-8. PubMed ID: 7900671
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative assessment of coronary vasoreactivity in humans in vivo. Importance of baseline vasomotor tone in atherosclerosis.
    Schächinger V; Zeiher AM
    Circulation; 1995 Oct; 92(8):2087-94. PubMed ID: 7554186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Abnormal coronary response to vasomotor stimuli: analogies between variant angina and X syndrome].
    Pozzati A; Morgagni GL; Ottani F; Bugiardini R; Lenzi S; Puddu P
    Cardiologia; 1989 May; 34(5):411-8. PubMed ID: 2503249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intracoronary nitroglycerin on myocardial blood flow and distribution in pacing-induced angina pectoris. Quantitative assessment by single-photon emission tomography.
    Liu P; Houle S; Burns RJ; Kimball B; Warbick-Cerone A; Johnston L; Gilday D; Weisel RD; McLaughlin PR
    Am J Cardiol; 1985 May; 55(11):1270-6. PubMed ID: 3922209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitrates in silent myocardial ischemia.
    Chatterjee K
    Am J Cardiol; 1987 Nov; 60(15):18H-25H. PubMed ID: 3120562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of the clinical manifestations of stenocardia in patients with ischemic heart disease, without myocardial infarct, in relation to the state of the coronary bed].
    Kuliev OA; Zingerman LS; Spasskiĭ AA; Rubanovich AI
    Ter Arkh; 1990; 62(4):52-8. PubMed ID: 2118280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary vasomotor response is related to the angiographic extent of coronary sclerosis in patients with stable angina pectoris.
    Asselbergs FW; Monnink SH; Veeger NJ; van Boven AJ; van Haelst PL; Jessurun GA; van Gilst WH; Tio RA
    Clin Sci (Lond); 2004 Feb; 106(2):115-20. PubMed ID: 12956627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The stress electrocardiogram in the evaluation of angina pectoris].
    Monteiro J
    Acta Med Port; 1997 Apr; 10(4):249-53. PubMed ID: 9341020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of coronary blood flow in man: methods and implications for clinical practice.
    Bradley AB; Baim DS
    Cardiovasc Clin; 1985; 15(1):67-82. PubMed ID: 2946409
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of patients with coronary artery disease.
    Gorlin R
    N Z Med J; 1973 Dec; 78(504):471-8. PubMed ID: 4205159
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronary artery spasms and heart disease.
    Marx JL
    Science; 1980 Jun; 208(4448):1127-30. PubMed ID: 6246580
    [No Abstract]   [Full Text] [Related]  

  • 14. [The physiopathology of angina pectoris].
    da Costa JT
    Acta Med Port; 1997 Apr; 10(4):233-41. PubMed ID: 9341018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, haemodynamic, and coronary angiographic correlates of angina pectoris in patients with severe aortic valve disease.
    Basta LL; Raines D; Najjar S; Kioschos JM
    Br Heart J; 1975 Feb; 37(2):150-7. PubMed ID: 804313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of coronary vasoconstriction in patients with coronary artery disease.
    Gunther S; Muller JE; Mudge GH; Grossman W
    Am J Cardiol; 1981 Jan; 47(1):157-62. PubMed ID: 6779618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic coronary obstruction as a cause of angina pectoris: implications regarding therapy.
    Epstein SE; Cannon RO; Watson RM; Leon MB; Bonow RO; Rosing DR
    Am J Cardiol; 1985 Jan; 55(3):61B-68B. PubMed ID: 3881918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical aspects of silent myocardial ischemia in patients with angina and other forms of coronary heart disease.
    Pepine CJ
    Am J Med; 1986 Apr; 80(4C):25-34. PubMed ID: 2871755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative sensitivity of intracoronary injection of acetylcholine for the induction of coronary spasm in patients with various types of angina pectoris.
    Miwa K; Fujita M; Ejiri M; Sasayama S
    Am Heart J; 1990 Sep; 120(3):544-50. PubMed ID: 2117844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms and therapy of silent myocardial ischemia and the effect of transdermal nitroglycerin.
    Shell WE
    Am J Cardiol; 1985 Dec; 56(17):23I-27I. PubMed ID: 3934951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.